InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 12/04/2017 7:59:35 AM

Monday, December 04, 2017 7:59:35 AM

Post# of 27623
BLRX - 1.12 Pre-market now at 1.17/1.18

BioLineRx Reports Positive Results From Trial of BL-8040 to Treat Acute Myeloid Leukemia; Shares Up 8% Early



Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.